Evidence map›Paper›PMID 40417913›Full record

ArticleBiometrics2025

Conformal predictive intervals in survival analysis: a resampling approach.

Jing Qin, Jin Piao, Jing Ning, Yu Shen

Abstract read
In one paragraph

Article in Biometrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing QinBiostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD 20892, United States.ORCID 0000-0003-2817-6326
Jin PiaoDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, CA 90032, United States.
Jing NingDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.ORCID 0000-0002-5289-331X
Yu ShenDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.ORCID 0000-0002-3899-7868

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Statistical Methods for Integration of Multiple Data Sources toward Precision Cancer MedicineR01CA269696 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI JING NING, YU SHEN · 2022 to 2026
$1.7M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA269696NIH HHS R01CA269696U.S. National Clinical Trials Network Statistics and Data Center U10CA180899
6 · The paper itself

Abstract

The distribution-free method of conformal prediction has gained considerable attention in computer science, machine learning, and statistics. Candès et al. extended this method to right-censored survival data, addressing right-censoring complexity by creating a covariate shift setting, extracting a subcohort of subjects with censoring times exceeding a fixed threshold. Their approach only estimates the lower prediction bound for type I censoring, where all subjects have available censoring times regardless of their failure status. In medical applications, we often encounter more general right-censored data, observing only the minimum of failure time and censoring time. Subjects with observed failure times have unavailable censoring times. To address this, we propose a bootstrap method to construct 1- as well as 2-sided conformal predictive intervals for general right-censored survival data under different working regression models. Through simulations, our method demonstrates excellent average coverage for the lower bound and good coverage for the 2-sided predictive interval, regardless of working model is correctly specified or not, particularly under moderate censoring. We further extend the proposed method to several directions in medical applications. We apply this method to predict breast cancer patients' future survival times based on tumor characteristics and treatment.

Indexed as

BiometryBreast NeoplasmsComputer SimulationFemaleHumansModels, StatisticalSurvival Analysisbootstrap samplingconformal predictionpredictive intervalright censored data

Identifiers

PMID40417913
PMCPMC12104816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.